Xeris Pharmaceuticals Obtains $625,000 New Funding

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=908242b9-cb18-427b-bc16-72272a7b86a0&Preview=1
Date
2/15/2013
Company Name
Xeris Pharmaceuticals
Mailing Address
3925 West Braker Lane Third Floor Austin, TX 78759
Company Description
Xeris is an Austin, Texas-based specialty pharmaceutical company developing patient-friendly injectables for indications in diabetes, epilepsy, and immunology. The company’s disruptive formulation and delivery technologies allow for the subcutaneous delivery of highly concentrated, non-aqueous paste and liquid formulations of all drug classes, including small molecules, peptides, proteins, antibodies, and nucleic-acid-based therapeutics.
Website
http://www.xerispharma.com
Transaction Type
Debt
Transaction Amount
$625,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing.
M&A Terms
Venture Investor
Undisclosed